Directory
>
Aron Knickerbocker
Aron Knickerbocker
Board Member | Aulos Bioscience
San Francisco, California, United States
Aron Knickerbocker
Summary
Aron Knickerbocker is a seasoned executive with over 30 years of experience in the life sciences sector, currently serving as the CEO of Aulos Bioscience, where he leads the development of innovative antibody therapies for cancer. He has a strong track record in strategic partnerships, mergers and acquisitions, and building high-performing teams across various biotechnology firms, including RayzeBio and FivePrime. Aron holds an MBA with Distinction from the University of Michigan and a Bachelor's with Honors in Biology from Washington University in St. Louis. His leadership roles extend to board positions at Phenomic AI and KAHR Medical, showcasing his influence in the biotechnology landscape. Passionate about collaboration and diversity, he strives to advance the commercialization of medicines that address unmet medical needs. His unique blend of scientific expertise and business acumen positions him as a key player in the biotechnology industry.
Aron Knickerbocker
Work Experience
Board Member at
Phenomic AI Inc.
March 2021 - Present
Chief Executive Officer at
Aulos Bioscience
March 2021 - Present
Chairman of the Board at
KAHR-Medical Ltd.
September 2020 - Present
Co-Founder at
RayzeBio
September 2019 - Present
Corporate Strategy and Business Development Consultant at
Self-Employed
March 2020 - March 2021
Chairman and Founding CEO at
RayzeBio
September 2019 - August 2020
Director Board Of Directors at
Five Prime Therapeutics, Inc.
October 2013 - September 2019
President and Chief Executive Officer at
Five Prime Therapeutics, Inc.
January 2018 - September 2019
Chief Operating Officer at
Five Prime Therapeutics, Inc.
September 2016 - December 2017
Chief Business Officer at
Five Prime Therapeutics, Inc.
April 2012 - February 2015
Vice President Of Business Development at
Five Prime Therapeutics, Inc.
September 2009 - April 2012
Senior Director, Business Development at
Genentech Foundation
August 2001 - September 2009
Director, Commercial Development, ALZA Corporation at
Johnson & Johnson
January 2000 - January 2001
Senior Manager, Corporate Development at
Amgen, Inc.
January 1996 - January 2000
Research Scientist at
Bristol Myers Squibb
January 1992 - January 1994
Aron Knickerbocker
Education
Ross School of Business, Mba With Distinction
January 1994 - January 1996
Washington University in St. Louis, Bachelor's With Honors
January 1987 - January 1991
Frequently Asked Questions about Aron Knickerbocker
What is Aron Knickerbocker email address?
Aron Knickerbocker's primary email address is *******@aulosbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Aron Knickerbocker work for?
Aron Knickerbocker is a Board Member at Aulos Bioscience, a company specializing in Commercial physical research.
Where Aron Knickerbocker graduated from?
Aron Knickerbocker holds a degree in Business Administration And Management from Ross School of Business.
How can I directly contact Aron Knickerbocker?
To contact Aron Knickerbocker directly, you can use the email address *******@aulosbio.com. Complete contact information is available upon registration with Muraena.
Who is Aron Knickerbocker?
Aron Knickerbocker is a seasoned executive with over 30 years of experience in the life sciences sector, currently serving as the CEO of Aulos Bioscience, where he leads the development of innovative antibody therapies for cancer. He has a strong track record in strategic partnerships, mergers and acquisitions, and building high-performing teams across various biotechnology firms, including RayzeBio and FivePrime. Aron holds an MBA with Distinction from the University of Michigan and a Bachelor's with Honors in Biology from Washington University in St. Louis. His leadership roles extend to board positions at Phenomic AI and KAHR Medical, showcasing his influence in the biotechnology landscape. Passionate about collaboration and diversity, he strives to advance the commercialization of medicines that address unmet medical needs. His unique blend of scientific expertise and business acumen positions him as a key player in the biotechnology industry.
Aron`s contact details
*******@aulosbio.com
******************@fiveprime.com
****@kahr-medical.com